Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Dynavax Technologies Corp (NASDAQ: DVAX) closed at $11.44 up 1.69% from its previous closing price of $11.25. In other words, the price has increased by $1.69 from its previous closing price. On the day, 2.28 million shares were traded.
Ratios:
For a deeper understanding of Dynavax Technologies Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.63. For the most recent quarter (mrq), Quick Ratio is recorded 9.91 and its Current Ratio is at 10.80. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.42.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Sell and sets its target price to $12 from $15 previously.
On February 01, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $20.
On September 27, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.JMP Securities initiated its Mkt Outperform rating on September 27, 2022, with a $22 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 24 ’25 when Novack David F sold 10,000 shares for $14.00 per share. The transaction valued at 140,000 led to the insider holds 8,078 shares of the business.
DAVID NOVACK bought 10,000 shares of DVAX for $140,000 on Mar 24 ’25. On Mar 18 ’25, another insider, Novack David F, who serves as the President & COO of the company, sold 14,020 shares for $13.58 each. As a result, the insider received 190,392 and left with 8,078 shares of the company.
Valuation Measures:
As of this moment, Dynavax’s Price-to-Earnings (P/E) ratio for their current fiscal year is 65.48, and their Forward P/E ratio for the next fiscal year is 20.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.24. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.13 while its Price-to-Book (P/B) ratio in mrq is 2.40.
Stock Price History:
Over the past 52 weeks, DVAX has reached a high of $14.63, while it has fallen to a 52-week low of $9.74. The 50-Day Moving Average of the stock is -13.44%, while the 200-Day Moving Average is calculated to be -5.34%.
Shares Statistics:
A total of 125.45M shares are outstanding, with a floating share count of 118.47M. Insiders hold about 4.66% of the company’s shares, while institutions hold 101.71% stake in the company.
